Skip to main content

Day: March 25, 2025

Aurora Spine Announces FDA 510(k) Clearance for the AERO™ Facet Fusion System

CARLSBAD, Calif., March 25, 2025 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company’s newest product, the AERO™ Facet Fusion System. The AERO MIS Facet Fusion System is a novel, patent-pending device designed to provide a minimally invasive solution for patients suffering from facet joint-related pain or instability. Cleared for use from spinal levels C2 to S1 (inclusive), the system can be used as a stand-alone facet fusion procedure or as an adjunct to larger spinal fusion surgeries. Engineered for earlier use in the continuum of care, AERO is ideal for patients experiencing mechanical...

Continue reading

BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates

In February 2025, BiomX announced a series of financings with total gross proceeds of approximately $12 million to support completion of Phase 2b study of BX004; topline results anticipated in Q1 2026 Topline Phase 2 results for BX211 in diabetic foot osteomyelitis (DFO) expected by end of March 2025 Initiated exploration and analysis of real-world evidence in people with Cystic Fibrosis (CF) on the relationship between Pseudomonas aeruginosa reduction and clinical outcomes, ahead of expected regulatory discussions in second half of 2025NESS ZIONA, Israel, March 25, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE, the “Company” or “BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced financial results for the fourth quarter...

Continue reading

Atour Lifestyle Holdings Limited Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

A total of 1,619 hotels, or 183,184 hotel rooms, in operation as of December 31, 2024. Net revenues for the fourth quarter of 2024 increased by 38.5% to RMB2,084 million (US$286 million), compared with RMB1,505 million for the same period of 2023. Net revenues for the full year of 2024 increased by 55.3% to RMB7,248 million (US$993 million), compared with RMB4,666 million for the full year of 2023. Net income for the fourth quarter of 2024 increased by 50.5% to RMB331 million (US$45 million), compared with RMB220 million for the same period of 2023. Net income for the full year of 2024 increased by 72.2% to RMB1,273 million (US$174 million), compared with RMB739 million for the full year of 2023. Adjusted net income (non-GAAP)1 for the fourth quarter of 2024 increased by 49.9% to RMB333 million (US$46 million), compared with RMB222 million...

Continue reading

BitFuFu Announces Full Year 2024 Unaudited Financial Results

SINGAPORE, March 25, 2025 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced its unaudited financial results for the full year ended December 31, 2024. Full Year 2024 Financial HighlightsTotal revenue was US$463.3 million in 2024, representing an increase of 63.1% from US$284.1 million in 2023 Revenue from cloud-mining solutions was US$271.0 million in 2024, representing an increase of 52.2% from US$178.0 million in 2023 Revenue from Bitcoin self-mining operations was US$157.5 million in 2024, representing an increase of 57.2% from US$100.2 million in 2023 Net income was US$54.0 million in 2024, representing an increase of 414.3% from US$10.5 million in 2023 Adjusted EBITDA (a non-GAAP metric) was US$117.5 million in...

Continue reading

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Phase 3 4WARD trial in chronic neutropenia now activated at ~90% of targeted trial sites; full enrollment expected in 3Q or 4Q 2025; top-line data anticipated in 2H 2026 4WARD trial protocol refined, increasing confidence in successful outcome 2024 XOLREMDI® net revenues $2.6 million since May launch; company expects ramp up in 2025 as targeted physician outreach increases patient finding and pull-through Conference call and webcast today at 8:30 am ET BOSTON, March 25, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today reported financial results for the fourth quarter and full year ended December 31, 2024, and highlighted key 2024 and recent events and expected upcoming milestones. “As expected, 2024 was a transformative year...

Continue reading

Pony AI Inc. Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results

NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) — Pony AI Inc. (“Pony.ai” or the “Company”) (Nasdaq: PONY), a global leader in the large-scale commercialization of autonomous mobility, today announced its unaudited financial results for the quarter and full year ended December 31, 2024. Dr. James Peng, Co-founder and Chief Executive Officer of Pony.ai, commented, “2024 marked a milestone year for Pony.ai as we transitioned to a public company. Our robotaxi-first, China-first, and tier-one cities-first approach has positioned us at the forefront of the race towards large-scale commercialization. The strategic partnerships with OEMs we have developed, also empowers us to rapidly scale production of our seventh-generation robotaxi. In 2025, we aim to build upon this momentum and accelerate beyond the inflection point of scaled commercialization,...

Continue reading

17 Education & Technology Group Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

BEIJING, March 25, 2025 (GLOBE NEWSWIRE) — 17 Education & Technology Group Inc. (NASDAQ: YQ) (“17EdTech” or the “Company”), a leading education technology company in China, today announced its unaudited financial results for the fourth quarter and the year ended December 31, 2024. Fourth Quarter 2024 Highlights1Net revenues were RMB36.6 million (US$5.0 million), compared with net revenues of RMB47.3 million in the fourth quarter of 2023. Gross margin was 33.6%, compared with 43.4% in the fourth quarter of 2023. Net loss was RMB63.7 million (US$8.7 million), compared with net loss of RMB98.4 million in the fourth quarter of 2023. Net loss as a percentage of net revenues was negative 174.2% in the fourth quarter of 2024, compared with negative 207.9% in the fourth quarter of 2023. Adjusted net loss2 (non-GAAP), which excluded...

Continue reading

Form 8.5 (EPT/RI) – Serinus Energy Plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Serinus Energy Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Serinus Energy Plc(d)        Date dealing undertaken: 24 March 2025(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass...

Continue reading

POST Luxembourg becomes first European operator to migrate to an autonomous, AI-ready fiber network

Press ReleasePOST Luxembourg becomes first European operator to migrate to an autonomous, AI-ready fiber networkPOST Luxembourg (POST) uses Nokia’s Lightspan access nodes and Altiplano automation platform to establish Europe’s first nation-wide autonomous fiber network. Nokia Altiplano Access Controller readies POST for the autonomous network era, helping to improve and streamline network operations, lower costs and enhance service delivery. Nokia Lightspan is a high-capacity fiber platform designed to meet operators’ increasing broadband demand.25 March 2025Amsterdam, Netherlands – Nokia today announced that POST aims to be Europe’s first operator to migrate its entire broadband infrastructure to a software-defined access network by the end of 2025. POST will deploy Nokia’s Altiplano Access Controller to help improve network operations...

Continue reading

Municipality Finance issues SEK 500 million tap under its MTN programme

Municipality Finance PlcStock exchange release 25 March 2025 at 10:00 am (EET) Municipality Finance issues SEK 500 million tap under its MTN programme On 26 March 2025 Municipality Finance Plc issues a new tranche in an amount of SEK 500 million to an existing series of notes issued on 21 February 2025. With the new tranche, the aggregate nominal amount of the notes is SEK 1.5 billion. The maturity date of the benchmark is 21 February 2028. The notes bear interest at a floating rate equal to 3-month Stibor plus 150 bps per annum. The notes are issued under MuniFin’s EUR 50 billion programme for the issuance of debt instruments. The offering circular, the supplemental offering circular and the final terms of the notes are available in English on the company’s website at https://www.kuntarahoitus.fi/en/for-investors. MuniFin has...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.